Bowel Preparation in Minimally Invasive Gynecologic Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18+
SponsorMuhammad Aslam

About this trial

This is a prospective randomized study of patients who are scheduled to undergo minimally invasive robotic gynecologic surgery. Patients will be randomized to require either pre-surgical bowel preparation vs. no bowel preparation. The effect of bowel preparation on intraoperative visualization, bowel handling, intestinal load and ease of surgery will be assessed. Patient comfort and satisfaction will be assessed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Scheduled to undergo minimally invasive robotic gynecologic surgery;

Age 18 years and above

Willing to perform an enema if randomized to the enema group

Able to read and understand English

Disqualifiers

Scheduled for open surgery

Younger than 18 years of age

Unwilling to perform an enema if randomized to the enema group

Unable to read and understand English

Trial design

Design model

Parallel

Treatments tested in this trial

  • Bowel Preparation

    Other intervention

    Individuals will perform a bowel preparation using a Fleet saline enema.

  • No bowel preparation

    Other intervention

    Subjects will not be required to perform bowel preparation before surgery.

Treatment groups

166 Participants
are divided into 2 treatment groups
Group A: Bowel PreparationExperimental treatment 1 intervention
Group B: No bowel preparationPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Physician reported ease of surgery

The investigator will complete a survey following each surgery about the ease of surgery. "Surgical field quality" will be scored as Outstanding, Good, Fair, or Poor. "Adequate visualization" is a yes/no response. "Difficulty in handling the bowel" is a yes/no response. There is room for free text.

Time frame
Immediately following surgery
2

Number of patients with a hospital readmission between discharge and 12 weeks post-discharge.

The number of patients with a hospital readmission between discharge from the hospital for the surgery and 12 weeks post-discharge from the hospital for the surgery will be collected via chart review.

Time frame
From discharge from the hospital for the surgery and 12 weeks post-discharge from the hospital for the surgery
3

Number of patients with a urinary tract infection between discharge from the hospital for the surgery and 12 weeks post-discharge from the hospital for the surgery

The number of patients who experience a urinary tract infection between discharge from the hospital for the surgery and 12 weeks post-discharge will be collected via chart review.

Time frame
Between discharge from the hospital for the surgery and 12 weeks post-discharge from the hospital for the surgery
4

Number of surgical site infections between discharge and 12 weeks post-discharge.

The number of patients with surgical site infections between discharge from the hospital for the surgery and 12 weeks post-discharge from the hospital for the surgery will be collected via chart review.

Time frame
Between discharge from the hospital for the surgery and 12 weeks post-discharge from the hospital for the surgery

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Muhammad Aslam

Lead sponsor

Henry Ford Health System

Sponsor institution